Maria A. Pletneva
No Rating Available
(Learn About Our Rating System)

Maria A. Pletneva, MD, PhD

Languages spoken: English, Russian

Specialties

  • Eosinophilic Gastrointestinal Disease
  • Pathology, Anatomical

Board Certification

American Board of Pathology (Sub: Hematology)
American Board of Pathology (Anatomic & Clinical)

Board Certification and Academic Information

Academic Departments Pathology -Associate Professor (Clinical)
Board Certification
American Board of Pathology (Sub: Hematology)
American Board of Pathology (Anatomic & Clinical)

Education history

Undergraduate Cellular and Molecular Biology and Genetics - University of Maryland B.S.
Undergraduate Biochemistry - University of Maryland B.S.
Professional Medical Medical Scientist Training Program - Johns Hopkins University School of Medicine M.D., Ph.D.
Residency Anatomic and Clinical Pathology - University of Michigan Health System Resident
Fellowship Hematopathology - University of Michigan Health System Fellow
Fellowship Surgical Pathology with concentration in Gastrointestinal Pathology - University of Michigan Health System Fellow

Selected Publications

Journal Article

  1. Williamson J, Pletneva M, Kim RG, Bhatia (2026). Mitigating Severe Ribociclib-Hepatotoxicity With Corticosteroids. Case reports in oncological medicine, 2026, 4222126.
  2. Turapov T, Uchida AM, Pletneva MA*, Peterson KA (2025). Gastrointestinal Tissue Eosinophil Quantification in Healthy Adult Volunteers. Gastroenterology, 169(1), 158-160.e2.
  3. Allen-Brady K, Clayton F, Hazel MW, Stevens J, Pyne AL, Pletneva MA, Cessna M, Stubben C, Robson J, Fang J, Peterson K (2025). Overlap of Genomic and Transcriptomic Genes Identified in Familial Eosinophilic Esophagitis. Gastroenterology, 168(6), 1101-1113.e18.
  4. Pyne AL, Uchida AM, Hazel MW, Pletneva MA, Allen-Brady K, Peterson K (2025). Differing Epithelial and Immunologic Activation Patterns Following Food Reintroduction Reveal Different Transcriptional Profiles in Active Eosinophilic Esophagitis. Gastroenterology, 168(3), 598-600.e3.
  5. Pyne AL, Schuman SS, Brintz BJ, Dodds W, Silon B, Pletneva MA, Peterson K (2025). Inflammatory Markers in Gastric Fluids Differentiate Patients With Eosinophilic Gastritis: Search for a Disease Screener. Clinical and translational gastroenterology, 16(10), e00898.
  6. Collins MH, Pan Z, Yang GY, Arva NC, Pletneva MA, Martin LJ, Aceves S, Chehade M, Dellon ES, Spergel JM, Menard-Katcher P, Peterson KA, Khoury P, Gonsalves N, Gupta SK, Davis CM, Falk GW, Wechsler JB, Pesek R, Hiremath G, Leung J, Katzka DA, Furuta GT, Rothenberg M (2025). Patient-Reported Outcome Scores Are Comparable in Multiregional Versus Uniregional Eosinophilic Esophagitis. Gastro hep advances, 4(9), 100753.
  7. Hausmann O, Schobert PP, Ose J, Himbert C, Pletneva M, Jedrzkiewicz J, Nguyen A, Lin T, Warby CA, Hardikar S, Peoples AR, Strehli I, Huang LC, Cohan JN, Pickron B, Scaife C, Li CI, Grady WM, Shibata D, Toriola AT, Schneider M, Figueiredo JC, Siegel EM, Gigic B, Herzig S, Ilozumba MN, Ulrich C (2025). Associations of Biomarkers of Systemic Inflammation, Angiogenesis, and Cell-to-Cell Adhesion With Tumor Budding Among Early-Onset and Later-Onset Colorectal Cancer Patients. Cancer medicine, 14(18), e71267.
  8. Pyne AL, Uchida AM, Hazel MW, Stubben CJ, Chang JW, Bailey DD, Gonsalves N, Allen-Brady K, Peterson KA, Pletneva M (2025). Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis. Diseases of the esophagus, 38(1),
  9. Pyne AL, Uchida AM, Hazel MW, Pletneva MA, Allen-Brady K, Peterson K (2024). Differing Epithelial and Immunologic Activation Patterns Following Food Reintroduction Reveal Different Transcriptional Profiles in Active Eosinophilic Esophagitis. Gastroenterology, 168(3), 598-600.e3.
  10. Martin LJ, Zhang X, Chehade M, Davis CM, Dellon ES, Falk GW, Gupta SK, Hirano I, Hiremath GS, Katzka DA, Khoury P, Leung J, Menard-Katcher P, Gonsalves N, Pesek RD, Spergel JM, Wechsler JB, Kliewer K, Arva NC, Collins MH, Pletneva M, Yang GY, Furuta GT, Rothenberg ME, Aceves S (2024). Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis. The Journal of allergy and clinical immunology, 154(5), 1232-1240.e12.
  11. Kim S, Ben-Baruch Morgenstern N, Osonoi K, Aceves SS, Arva NC, Chehade M, Collins MH, Dellon ES, Falk GW, Furuta GT, Gonsalves NP, Gupta SK, Hirano I, Hiremath G, Katzka DA, Khoury P, Leung J, Pesek R, Peterson KA, Pletneva MA, Spergel JM, Wechsler JB, Yang GY, Rothenberg ME, Shoda (2024). Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis. The journal of allergy and clinical immunology. In practice, 12(12), 3346-3355.e1.
  12. Sato H, Dellon ES, Aceves SS, Arva NC, Chehade M, Collins MH, Davis CM, Falk GW, Furuta GT, Gonsalves NP, Gupta SK, Hirano I, Hiremath G, Katzka DA, Khoury P, Leung J, Menard-Katcher P, Pesek R, Peterson KA, Pletneva MA, Spergel JM, Wechsler JB, Yang GY, Rothenberg ME, Shoda (2024). Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis. The Journal of allergy and clinical immunology, 154(2), 375-386.e4.
  13. Hirano I, Dellon ES, Falk GW, Gonsalves NP, Furuta GT, Bredenoord AJ, ASCENT WORKING GROU (2024). Ascending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis. Gastroenterology, 166(1), 1-10.
  14. Genta RM, Turner KO, Collins MH, Wechsler JB, Arva NC, Pletneva MA, Dellon ES, Walker M (2024). Quantification of Mucosal Mast Cells in the Gastrointestinal Tract: A Primer for Practicing Pathologists. Archives of pathology & laboratory medicine, 148(2), e25-e35.
  15. Boylan KE, Kanth P, Delker D, Hazel MW, Boucher KM, Affolter K, Clayton F, Evason KJ, Jedrzkiewicz J, Pletneva M, Samowitz W, Swanson E, Bronner M (2023). Three pathologic criteria for reproducible diagnosis of colonic sessile serrated lesion versus hyperplastic polyp. Human pathology, 137, 25-35.
  16. Eisele Y, Mallea PM, Gigic B, Stephens WZ, Warby CA, Buhrke K, Lin T, Boehm J, Schrotz-King P, Hardikar S, Huang LC, Pickron TB, Scaife CL, Viskochil R, Koelsch T, Peoples AR, Pletneva MA, Bronner M, Schneider M, Ulrich AB, Swanson EA, Toriola AT, Shibata D, Li CI, Siegel EM, Figueiredo J, Janssen KP, Hauner H, Round J, Ulrich CM, Holowatyj AN, Ose (2021). Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study. Clinical colorectal cancer, 20(3), e165-e172.

Review

  1. Collins MH, Arva NC, Bernieh A, Lopez-Nunez O, Pletneva M, Yang G (2024). Histopathology of Eosinophilic Esophagitis. Immunology and allergy clinics of North America, 44(2), 205-221.
  2. Arva NC, Bernieh A, Lopez-Nunez O, Pletneva M, Yang GY, Collins M (2024). Histopathology of Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis. Immunology and allergy clinics of North America, 44(2), 369-381.

Letter

  1. Uchida AM, Peterson KA, Pletneva M (2025). Reply. Gastroenterology, 169(7), 1573.
  2. Talley NJ, Peterson KA, Genta RM, Chang AT, Dellon ES, Sandborn WJ, 019 Study Team, Lacy BE, Chehade M, Hirano I, Gonsalves N, Lembo A, Schmitt CM, Rothenberg ME, Jain N, Pletneva MA, Turner KO, Youngblood B (2023). High Discovery Rate of Duodenal and Gastric Eosinophilia in Patients With Unexplained Moderate-Severe Abdominal Symptoms: A Prospective US Multisite Study. Gastroenterology, 164(4), 680-683.e2.
  3. Arva N, Genta RM, Pletneva M, Walker MM, Yang GY, Collins M (2022). Eosinophilic Gastrointestinal Disorders: A new Path. Pediatric and developmental pathology, 25(5), 568-569.
  4. Radojcic V, Pletneva M, Lee CJ, Ivcevic S, Sarantopoulos S, Couriel (2021). Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease. British journal of haematology, 195(2), e120-e122.